{"id":516378,"date":"2021-07-22T08:05:35","date_gmt":"2021-07-22T12:05:35","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/"},"modified":"2021-07-22T08:05:35","modified_gmt":"2021-07-22T12:05:35","slug":"blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/","title":{"rendered":"Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n CAMBRIDGE, Mass.<\/span>, July 22, 2021<\/span> \/PRNewswire\/ —\u00a0Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday<\/span>, July 29, 2021 to report its second quarter 2021 financial results and provide a corporate update. <\/p>\n

\n

\n
\n \"Print\"
\n <\/a>\n <\/p>\n<\/p><\/div>\n

To access the live conference call, please dial 844-200-6205 (domestic) or +44-208-0682-558 (international), and refer to conference ID 619159. A webcast of the call will also be available under “Events and Presentations” in the Investors & Media section of the Blueprint Medicines website at http:\/\/ir.blueprintmedicines.com\/<\/a>. The archived webcast will be available on Blueprint Medicines’ website approximately two hours after the conference call and will be available for 30 days following the call. <\/p>\n

\n About Blueprint Medicines<\/b>\n <\/p>\n

Blueprint Medicines\u00a0is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering approved medicines directly to patients in\u00a0the United States\u00a0and\u00a0Europe, and we are globally advancing multiple programs for genomically defined cancers, systemic mastocytosis, and cancer immunotherapy. \u00a0For more information, visit\u00a0www.BlueprintMedicines.com<\/a><\/u>\u00a0and follow us on\u00a0Twitter<\/a><\/u>\u00a0(@BlueprintMeds) and\u00a0LinkedIn<\/a><\/u>.<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021-301338751.html<\/a><\/p>\n

SOURCE Blueprint Medicines Corporation<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire CAMBRIDGE, Mass., July 22, 2021 \/PRNewswire\/ —\u00a0Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, July 29, 2021 to report its second quarter 2021 financial results and provide a corporate update. To access the live conference call, please dial 844-200-6205 (domestic) or +44-208-0682-558 (international), and refer to conference ID 619159. A webcast of the call will also be available under “Events and Presentations” in the Investors & Media section of the Blueprint Medicines website at http:\/\/ir.blueprintmedicines.com\/. The archived webcast will be available on Blueprint Medicines’ website approximately two hours after the conference call and will be available for 30 days following the call. About … <\/p>\n

Continue reading “Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-516378","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBlueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire CAMBRIDGE, Mass., July 22, 2021 \/PRNewswire\/ —\u00a0Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, July 29, 2021 to report its second quarter 2021 financial results and provide a corporate update. To access the live conference call, please dial 844-200-6205 (domestic) or +44-208-0682-558 (international), and refer to conference ID 619159. A webcast of the call will also be available under “Events and Presentations” in the Investors & Media section of the Blueprint Medicines website at http:\/\/ir.blueprintmedicines.com\/. The archived webcast will be available on Blueprint Medicines’ website approximately two hours after the conference call and will be available for 30 days following the call. About … Continue reading "Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-22T12:05:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/221118\/blueprint_medicines_logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021\",\"datePublished\":\"2021-07-22T12:05:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\\\/\"},\"wordCount\":277,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/221118\\\/blueprint_medicines_logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\\\/\",\"name\":\"Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/221118\\\/blueprint_medicines_logo.jpg\",\"datePublished\":\"2021-07-22T12:05:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/221118\\\/blueprint_medicines_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/221118\\\/blueprint_medicines_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/","og_locale":"en_US","og_type":"article","og_title":"Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021 - Market Newsdesk","og_description":"PR Newswire CAMBRIDGE, Mass., July 22, 2021 \/PRNewswire\/ —\u00a0Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, July 29, 2021 to report its second quarter 2021 financial results and provide a corporate update. To access the live conference call, please dial 844-200-6205 (domestic) or +44-208-0682-558 (international), and refer to conference ID 619159. A webcast of the call will also be available under “Events and Presentations” in the Investors & Media section of the Blueprint Medicines website at http:\/\/ir.blueprintmedicines.com\/. The archived webcast will be available on Blueprint Medicines’ website approximately two hours after the conference call and will be available for 30 days following the call. About … Continue reading \"Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-22T12:05:35+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/221118\/blueprint_medicines_logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021","datePublished":"2021-07-22T12:05:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/"},"wordCount":277,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/221118\/blueprint_medicines_logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/","name":"Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/221118\/blueprint_medicines_logo.jpg","datePublished":"2021-07-22T12:05:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/221118\/blueprint_medicines_logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/221118\/blueprint_medicines_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/blueprint-medicines-to-report-second-quarter-2021-financial-results-on-thursday-july-29-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/516378","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=516378"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/516378\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=516378"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=516378"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=516378"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}